Torthaí cuardaigh - Wechalekar, Ashutosh

The Evolving Epidemiology of Amyloidosis de réir Wechalekar, Ashutosh D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Update on treatment of light chain amyloidosis de réir Mahmood, Shameem, Palladini, Giovanni, Sanchorawala, Vaishali, Wechalekar, Ashutosh

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Thoracic amyloidomas: Two case reports of an evasive diagnosis de réir Cresner, Rosie, Mahmood, Shameem, Chen, Jane, Rowan, Camilla, Wechalekar, Ashutosh D

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Updates in Cardiac Amyloidosis: A Review de réir Banypersad, Sanjay M., Moon, James C., Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

[(18)F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström’s Macroglobulinemia de réir Fox, Thomas A., Lunn, Michael, Wechalekar, Ashutosh, Bomanji, Jamshed, Wan, Simon, D’Sa, Shirley

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of c... de réir Wechalekar, Ashutosh D., Gillmore, Julian D., Wassef, Nancy, Lachmann, Helen J., Whelan, Carol, Hawkins, Philip N.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds de réir Wagner, T., Page, J., Burniston, M., Skillen, A., Ross, J. C., Manwani, R., McCool, D., Hawkins, P. N., Wechalekar, Ashutosh D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Two types of amyloid in a single heart de réir Mahmood, Shameem, Gilbertson, Janet A., Rendell, Nigel, Whelan, Carol J., Lachmann, Helen J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study de réir Banypersad, Sanjay M, Fontana, Marianna, Maestrini, Viviana, Sado, Daniel, White, Steven K, Treibel, Thomas A, Lachmann, Helen, Wechalekar, Ashutosh, Hawkins, Philip N, Moon, James

Faigh an téacs iomlán Faigh an téacs iomlán

Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain Amyloidosis de réir Gillmore, Julian D., Lachmann, Helen J., Rowczenio, Dorota, Gilbertson, Janet A., Zeng, Cai-Hong, Liu, Zhi-Hong, Li, Lei-Shi, Wechalekar, Ashutosh, Hawkins, Philip N.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis de réir Sharpley, Faye A., Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Fontana, Marianna, Hawkins, Philip N., Wechalekar, Ashutosh D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis de réir Sachchithanantham, Sajitha, Offer, Mark, Venner, Christopher, Mahmood, Shameem A., Foard, Darren, Rannigan, Lisa, Lane, Thirusha, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Deferred autologous stem cell transplantation in systemic AL amyloidosis de réir Manwani, Richa, Hegenbart, Ute, Mahmood, Shameem, Sachchithanantham, Sajitha, Kyriakou, Charalampia, Yong, Kwee, Popat, Rakesh, Rabin, Neil, Whelan, Carol, Dittrich, Tobias, Kimmich, Christoph, Hawkins, Philip, Schönland, Stefan, Wechalekar, Ashutosh

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria de réir Sharpley, Faye A., Fontana, Marianna, Martinez-Naharro, Ana, Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic de réir Kastritis, Efstathios, Wechalekar, Ashutosh, Schönland, Stefan, Sanchorawala, Vaishali, Merlini, Giampaolo, Palladini, Giovanni, Minnema, Monique, Roussel, Murielle, Jaccard, Arnaud, Hegenbart, Ute, Kumar, Shaji, Cibeira, Maria T., Blade, Joan, Dimopoulos, Meletios A.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis de réir Ravichandran, Sriram, Law, Steven, Mahmood, Shameem, Wisniowski, Brenden, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis de réir Dungu, Jason, Whelan, Carol J, Gibbs, Simon D, Pinney, Jennifer H, Banypersad, Sanjay M, Venner, Christopher P, Lachmann, Helen J, Wechalekar, Ashutosh, Gillmore, Julian D, Hawkins, Philip N, Anderson, Lisa

Faigh an téacs iomlán Faigh an téacs iomlán

Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis de réir Manwani, Richa, Foard, Darren, Mahmood, Shameem, Sachchithanantham, Sajitha, Lane, Thirusha, Quarta, Cristina, Youngstein, Taryn, Rezk, Tamer, Lachmann, Helen J, Gillmore, Julian D., Fontana, Marianna, Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib de réir Ravichandran, Sriram, Cohen, Oliver C., Law, Steven, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Sachchithanantham, Sajitha, Mahmood, Shameem, Hawkins, Philip N., Wechalekar, Ashutosh D.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis de réir Rezk, Tamer, Gilbertson, Janet A, Mangione, P Patrizia, Rowczenio, Dorota, Rendell, Nigel B, Canetti, Diana, Lachmann, Helen J, Wechalekar, Ashutosh D, Bass, Paul, Hawkins, Philip N, Bellotti, Vittorio, Taylor, Graham W, Gillmore, Julian D

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán